Polygenic scores in Familial breast cancer cases with and without pathogenic variants and the risk of contralateral breast cancer
Abstract Background Polygenic risk scores (PRS) are not yet standard in clinical risk assessments for familial breast cancer in Sweden. This study evaluated the distribution and impact of an established PRS (PRS313) in women undergoing clinical sequencing for hereditary breast cancer. Findings We in...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2025-09-01
|
| Edice: | Breast Cancer Research |
| On-line přístup: | https://doi.org/10.1186/s13058-025-02107-5 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
